| HOME >> BIOLOGY >> TECHNOLOGY |
Mr. McEntee has served as WaferGen's director of engineering since 2007. He possesses broad expertise in the development of automated manufacturing equipment, particularly in advancing new technologies from the design stage to market-ready products. Prior to joining WaferGen, Mr. McEnteee held various management positions with Potter Drilling, Xyratex International and Agilent Technologies. At Agilent, he managed a team of engineers responsible for developing the company's microarray manufacturing capability and also led the company's effort to define an optimal automation strategy for the company's microarray technology platform.
About WaferGen
WaferGen Biosystems, Inc. is a leader in the development, manufacture
and sale of state-of-the-art systems for gene expression, genotyping, cell
biology and stem cell research for the life science and pharmaceutical
industries. The company is actively developing its SmartChip(TM) product
for the gene expression and genotyping markets. SmartChip(TM) is being
developed as the first whole genome, high throughput gene expression
real-time polymerase chain reaction (PCR) platform and promises to deliver
significant speed and cost advantages to researchers in the gene expression
and genotyping markets. WaferGen currently markets its SmartSlide(TM)
family of products to companies and organizations involved in stem cell and
cell biology research. SmartSlide(TM), which was launched in 2006,
represents the first fluidics integrated micro-incubators enabling cell
biology and stem cell research. Representative SmartSlide(TM) customers
include Harvard University, Mayo Clinic, Memorial Sloan-Kettering Cancer
Center, Abbott Labs, and the
'/>"/>
| SOURCE WaferGen Biosystems Inc. Copyright©2008 PR Newswire. All rights reserved |